Shockwave Medical – Talk Bio

Actionable Insights Powered by AI

J&J Targets $100 Billion in 2026 Sales Despite Stelara Patent Cliff

4 days ago talkbio0Tagged 2026, Darzalex, J&J, Johnson & Johnson, medtech, Neoplasms, Patent Cliff, Sales - occupational activity, Shockwave Medical, Stelara

Johnson & Johnson; J&J; 2026 sales; $100 billion; Stelara; patent cliff; DARZALEX; oncology; MedTech; Shockwave Medical

J&J’s Shockwave Medical Launches Novel Javelin Intravascular Lithotripsy Catheter for Treating Calcified Peripheral Artery Disease

11 months ago11 months ago talkbio0Tagged Calcified (qualifier), Intravascular, Lithotripsy, Medical Devices, Peripheral Arterial Diseases, Shockwave Medical, vascular intervention

Intravascular lithotripsy, peripheral artery disease, calcified lesions, Shockwave Medical, Johnson & Johnson, medical device, vascular intervention

Johnson & Johnson Raises 2024 Guidance Following Acquisition of Shockwave Medical

2 years ago talkbio0Tagged 2024, Acquisition (action), Advice, billion-dollar, Johnson and Johnson, Shockwave Medical

Johnson & Johnson, Shockwave Medical, 2024 Guidance, Acquisition, Billion-Dollar Potential